Global Pertussis Vaccination Market Growth 2023-2029

The report requires updating with new data and is sent in 48 hours after order is placed.
Pertussis vaccine is a vaccine that protects against whooping cough. There are two main types: whole-cell vaccines and acellular vaccines. The whole-cell vaccine is about 78% effective while the acellular vaccine is 71–85% effective.
LPI (LP Information)' newest research report, the “Pertussis Vaccination Industry Forecast” looks at past sales and reviews total world Pertussis Vaccination sales in 2022, providing a comprehensive analysis by region and market sector of projected Pertussis Vaccination sales for 2023 through 2029. With Pertussis Vaccination sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Pertussis Vaccination industry.
This Insight Report provides a comprehensive analysis of the global Pertussis Vaccination landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Pertussis Vaccination portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Pertussis Vaccination market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Pertussis Vaccination and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Pertussis Vaccination.
The global Pertussis Vaccination market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Pertussis Vaccination is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Pertussis Vaccination is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Pertussis Vaccination is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Pertussis Vaccination players cover Sanofi Pasteur, GSK, Mitsubishi Tanabe Pharma, KM Biologics, Wuhan Institute of Biological Products, Walvax Biotechnology, Chengdu Institute of Biological Products and Minhai Biotechnology, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Pertussis Vaccination market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
What is the 10-year outlook for the global Pertussis Vaccination market?
What factors are driving Pertussis Vaccination market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Pertussis Vaccination market opportunities vary by end market size?
How does Pertussis Vaccination break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
Pertussis vaccine is a vaccine that protects against whooping cough. There are two main types: whole-cell vaccines and acellular vaccines. The whole-cell vaccine is about 78% effective while the acellular vaccine is 71–85% effective.
LPI (LP Information)' newest research report, the “Pertussis Vaccination Industry Forecast” looks at past sales and reviews total world Pertussis Vaccination sales in 2022, providing a comprehensive analysis by region and market sector of projected Pertussis Vaccination sales for 2023 through 2029. With Pertussis Vaccination sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Pertussis Vaccination industry.
This Insight Report provides a comprehensive analysis of the global Pertussis Vaccination landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Pertussis Vaccination portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Pertussis Vaccination market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Pertussis Vaccination and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Pertussis Vaccination.
The global Pertussis Vaccination market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Pertussis Vaccination is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Pertussis Vaccination is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Pertussis Vaccination is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Pertussis Vaccination players cover Sanofi Pasteur, GSK, Mitsubishi Tanabe Pharma, KM Biologics, Wuhan Institute of Biological Products, Walvax Biotechnology, Chengdu Institute of Biological Products and Minhai Biotechnology, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Pertussis Vaccination market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
- Acellular Vaccines
- Whole-cell Vaccines
- 12 Months Below
- 12 Months Above
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Sanofi Pasteur
- GSK
- Mitsubishi Tanabe Pharma
- KM Biologics
- Wuhan Institute of Biological Products
- Walvax Biotechnology
- Chengdu Institute of Biological Products
- Minhai Biotechnology
What is the 10-year outlook for the global Pertussis Vaccination market?
What factors are driving Pertussis Vaccination market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Pertussis Vaccination market opportunities vary by end market size?
How does Pertussis Vaccination break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Pertussis Vaccination Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Pertussis Vaccination by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Pertussis Vaccination by Country/Region, 2018, 2022 & 2029
2.2 Pertussis Vaccination Segment by Type
2.2.1 Acellular Vaccines
2.2.2 Whole-cell Vaccines
2.3 Pertussis Vaccination Sales by Type
2.3.1 Global Pertussis Vaccination Sales Market Share by Type (2018-2023)
2.3.2 Global Pertussis Vaccination Revenue and Market Share by Type (2018-2023)
2.3.3 Global Pertussis Vaccination Sale Price by Type (2018-2023)
2.4 Pertussis Vaccination Segment by Application
2.4.1 12 Months Below
2.4.2 12 Months Above
2.5 Pertussis Vaccination Sales by Application
2.5.1 Global Pertussis Vaccination Sale Market Share by Application (2018-2023)
2.5.2 Global Pertussis Vaccination Revenue and Market Share by Application (2018-2023)
2.5.3 Global Pertussis Vaccination Sale Price by Application (2018-2023)
3 GLOBAL PERTUSSIS VACCINATION BY COMPANY
3.1 Global Pertussis Vaccination Breakdown Data by Company
3.1.1 Global Pertussis Vaccination Annual Sales by Company (2018-2023)
3.1.2 Global Pertussis Vaccination Sales Market Share by Company (2018-2023)
3.2 Global Pertussis Vaccination Annual Revenue by Company (2018-2023)
3.2.1 Global Pertussis Vaccination Revenue by Company (2018-2023)
3.2.2 Global Pertussis Vaccination Revenue Market Share by Company (2018-2023)
3.3 Global Pertussis Vaccination Sale Price by Company
3.4 Key Manufacturers Pertussis Vaccination Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Pertussis Vaccination Product Location Distribution
3.4.2 Players Pertussis Vaccination Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR PERTUSSIS VACCINATION BY GEOGRAPHIC REGION
4.1 World Historic Pertussis Vaccination Market Size by Geographic Region (2018-2023)
4.1.1 Global Pertussis Vaccination Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Pertussis Vaccination Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Pertussis Vaccination Market Size by Country/Region (2018-2023)
4.2.1 Global Pertussis Vaccination Annual Sales by Country/Region (2018-2023)
4.2.2 Global Pertussis Vaccination Annual Revenue by Country/Region (2018-2023)
4.3 Americas Pertussis Vaccination Sales Growth
4.4 APAC Pertussis Vaccination Sales Growth
4.5 Europe Pertussis Vaccination Sales Growth
4.6 Middle East & Africa Pertussis Vaccination Sales Growth
5 AMERICAS
5.1 Americas Pertussis Vaccination Sales by Country
5.1.1 Americas Pertussis Vaccination Sales by Country (2018-2023)
5.1.2 Americas Pertussis Vaccination Revenue by Country (2018-2023)
5.2 Americas Pertussis Vaccination Sales by Type
5.3 Americas Pertussis Vaccination Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Pertussis Vaccination Sales by Region
6.1.1 APAC Pertussis Vaccination Sales by Region (2018-2023)
6.1.2 APAC Pertussis Vaccination Revenue by Region (2018-2023)
6.2 APAC Pertussis Vaccination Sales by Type
6.3 APAC Pertussis Vaccination Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Pertussis Vaccination by Country
7.1.1 Europe Pertussis Vaccination Sales by Country (2018-2023)
7.1.2 Europe Pertussis Vaccination Revenue by Country (2018-2023)
7.2 Europe Pertussis Vaccination Sales by Type
7.3 Europe Pertussis Vaccination Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Pertussis Vaccination by Country
8.1.1 Middle East & Africa Pertussis Vaccination Sales by Country (2018-2023)
8.1.2 Middle East & Africa Pertussis Vaccination Revenue by Country (2018-2023)
8.2 Middle East & Africa Pertussis Vaccination Sales by Type
8.3 Middle East & Africa Pertussis Vaccination Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Pertussis Vaccination
10.3 Manufacturing Process Analysis of Pertussis Vaccination
10.4 Industry Chain Structure of Pertussis Vaccination
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Pertussis Vaccination Distributors
11.3 Pertussis Vaccination Customer
12 WORLD FORECAST REVIEW FOR PERTUSSIS VACCINATION BY GEOGRAPHIC REGION
12.1 Global Pertussis Vaccination Market Size Forecast by Region
12.1.1 Global Pertussis Vaccination Forecast by Region (2024-2029)
12.1.2 Global Pertussis Vaccination Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Pertussis Vaccination Forecast by Type
12.7 Global Pertussis Vaccination Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Sanofi Pasteur
13.1.1 Sanofi Pasteur Company Information
13.1.2 Sanofi Pasteur Pertussis Vaccination Product Portfolios and Specifications
13.1.3 Sanofi Pasteur Pertussis Vaccination Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Sanofi Pasteur Main Business Overview
13.1.5 Sanofi Pasteur Latest Developments
13.2 GSK
13.2.1 GSK Company Information
13.2.2 GSK Pertussis Vaccination Product Portfolios and Specifications
13.2.3 GSK Pertussis Vaccination Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 GSK Main Business Overview
13.2.5 GSK Latest Developments
13.3 Mitsubishi Tanabe Pharma
13.3.1 Mitsubishi Tanabe Pharma Company Information
13.3.2 Mitsubishi Tanabe Pharma Pertussis Vaccination Product Portfolios and Specifications
13.3.3 Mitsubishi Tanabe Pharma Pertussis Vaccination Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Mitsubishi Tanabe Pharma Main Business Overview
13.3.5 Mitsubishi Tanabe Pharma Latest Developments
13.4 KM Biologics
13.4.1 KM Biologics Company Information
13.4.2 KM Biologics Pertussis Vaccination Product Portfolios and Specifications
13.4.3 KM Biologics Pertussis Vaccination Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 KM Biologics Main Business Overview
13.4.5 KM Biologics Latest Developments
13.5 Wuhan Institute of Biological Products
13.5.1 Wuhan Institute of Biological Products Company Information
13.5.2 Wuhan Institute of Biological Products Pertussis Vaccination Product Portfolios and Specifications
13.5.3 Wuhan Institute of Biological Products Pertussis Vaccination Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Wuhan Institute of Biological Products Main Business Overview
13.5.5 Wuhan Institute of Biological Products Latest Developments
13.6 Walvax Biotechnology
13.6.1 Walvax Biotechnology Company Information
13.6.2 Walvax Biotechnology Pertussis Vaccination Product Portfolios and Specifications
13.6.3 Walvax Biotechnology Pertussis Vaccination Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Walvax Biotechnology Main Business Overview
13.6.5 Walvax Biotechnology Latest Developments
13.7 Chengdu Institute of Biological Products
13.7.1 Chengdu Institute of Biological Products Company Information
13.7.2 Chengdu Institute of Biological Products Pertussis Vaccination Product Portfolios and Specifications
13.7.3 Chengdu Institute of Biological Products Pertussis Vaccination Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Chengdu Institute of Biological Products Main Business Overview
13.7.5 Chengdu Institute of Biological Products Latest Developments
13.8 Minhai Biotechnology
13.8.1 Minhai Biotechnology Company Information
13.8.2 Minhai Biotechnology Pertussis Vaccination Product Portfolios and Specifications
13.8.3 Minhai Biotechnology Pertussis Vaccination Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Minhai Biotechnology Main Business Overview
13.8.5 Minhai Biotechnology Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Pertussis Vaccination Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Pertussis Vaccination by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Pertussis Vaccination by Country/Region, 2018, 2022 & 2029
2.2 Pertussis Vaccination Segment by Type
2.2.1 Acellular Vaccines
2.2.2 Whole-cell Vaccines
2.3 Pertussis Vaccination Sales by Type
2.3.1 Global Pertussis Vaccination Sales Market Share by Type (2018-2023)
2.3.2 Global Pertussis Vaccination Revenue and Market Share by Type (2018-2023)
2.3.3 Global Pertussis Vaccination Sale Price by Type (2018-2023)
2.4 Pertussis Vaccination Segment by Application
2.4.1 12 Months Below
2.4.2 12 Months Above
2.5 Pertussis Vaccination Sales by Application
2.5.1 Global Pertussis Vaccination Sale Market Share by Application (2018-2023)
2.5.2 Global Pertussis Vaccination Revenue and Market Share by Application (2018-2023)
2.5.3 Global Pertussis Vaccination Sale Price by Application (2018-2023)
3 GLOBAL PERTUSSIS VACCINATION BY COMPANY
3.1 Global Pertussis Vaccination Breakdown Data by Company
3.1.1 Global Pertussis Vaccination Annual Sales by Company (2018-2023)
3.1.2 Global Pertussis Vaccination Sales Market Share by Company (2018-2023)
3.2 Global Pertussis Vaccination Annual Revenue by Company (2018-2023)
3.2.1 Global Pertussis Vaccination Revenue by Company (2018-2023)
3.2.2 Global Pertussis Vaccination Revenue Market Share by Company (2018-2023)
3.3 Global Pertussis Vaccination Sale Price by Company
3.4 Key Manufacturers Pertussis Vaccination Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Pertussis Vaccination Product Location Distribution
3.4.2 Players Pertussis Vaccination Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR PERTUSSIS VACCINATION BY GEOGRAPHIC REGION
4.1 World Historic Pertussis Vaccination Market Size by Geographic Region (2018-2023)
4.1.1 Global Pertussis Vaccination Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Pertussis Vaccination Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Pertussis Vaccination Market Size by Country/Region (2018-2023)
4.2.1 Global Pertussis Vaccination Annual Sales by Country/Region (2018-2023)
4.2.2 Global Pertussis Vaccination Annual Revenue by Country/Region (2018-2023)
4.3 Americas Pertussis Vaccination Sales Growth
4.4 APAC Pertussis Vaccination Sales Growth
4.5 Europe Pertussis Vaccination Sales Growth
4.6 Middle East & Africa Pertussis Vaccination Sales Growth
5 AMERICAS
5.1 Americas Pertussis Vaccination Sales by Country
5.1.1 Americas Pertussis Vaccination Sales by Country (2018-2023)
5.1.2 Americas Pertussis Vaccination Revenue by Country (2018-2023)
5.2 Americas Pertussis Vaccination Sales by Type
5.3 Americas Pertussis Vaccination Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Pertussis Vaccination Sales by Region
6.1.1 APAC Pertussis Vaccination Sales by Region (2018-2023)
6.1.2 APAC Pertussis Vaccination Revenue by Region (2018-2023)
6.2 APAC Pertussis Vaccination Sales by Type
6.3 APAC Pertussis Vaccination Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Pertussis Vaccination by Country
7.1.1 Europe Pertussis Vaccination Sales by Country (2018-2023)
7.1.2 Europe Pertussis Vaccination Revenue by Country (2018-2023)
7.2 Europe Pertussis Vaccination Sales by Type
7.3 Europe Pertussis Vaccination Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Pertussis Vaccination by Country
8.1.1 Middle East & Africa Pertussis Vaccination Sales by Country (2018-2023)
8.1.2 Middle East & Africa Pertussis Vaccination Revenue by Country (2018-2023)
8.2 Middle East & Africa Pertussis Vaccination Sales by Type
8.3 Middle East & Africa Pertussis Vaccination Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Pertussis Vaccination
10.3 Manufacturing Process Analysis of Pertussis Vaccination
10.4 Industry Chain Structure of Pertussis Vaccination
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Pertussis Vaccination Distributors
11.3 Pertussis Vaccination Customer
12 WORLD FORECAST REVIEW FOR PERTUSSIS VACCINATION BY GEOGRAPHIC REGION
12.1 Global Pertussis Vaccination Market Size Forecast by Region
12.1.1 Global Pertussis Vaccination Forecast by Region (2024-2029)
12.1.2 Global Pertussis Vaccination Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Pertussis Vaccination Forecast by Type
12.7 Global Pertussis Vaccination Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Sanofi Pasteur
13.1.1 Sanofi Pasteur Company Information
13.1.2 Sanofi Pasteur Pertussis Vaccination Product Portfolios and Specifications
13.1.3 Sanofi Pasteur Pertussis Vaccination Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Sanofi Pasteur Main Business Overview
13.1.5 Sanofi Pasteur Latest Developments
13.2 GSK
13.2.1 GSK Company Information
13.2.2 GSK Pertussis Vaccination Product Portfolios and Specifications
13.2.3 GSK Pertussis Vaccination Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 GSK Main Business Overview
13.2.5 GSK Latest Developments
13.3 Mitsubishi Tanabe Pharma
13.3.1 Mitsubishi Tanabe Pharma Company Information
13.3.2 Mitsubishi Tanabe Pharma Pertussis Vaccination Product Portfolios and Specifications
13.3.3 Mitsubishi Tanabe Pharma Pertussis Vaccination Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Mitsubishi Tanabe Pharma Main Business Overview
13.3.5 Mitsubishi Tanabe Pharma Latest Developments
13.4 KM Biologics
13.4.1 KM Biologics Company Information
13.4.2 KM Biologics Pertussis Vaccination Product Portfolios and Specifications
13.4.3 KM Biologics Pertussis Vaccination Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 KM Biologics Main Business Overview
13.4.5 KM Biologics Latest Developments
13.5 Wuhan Institute of Biological Products
13.5.1 Wuhan Institute of Biological Products Company Information
13.5.2 Wuhan Institute of Biological Products Pertussis Vaccination Product Portfolios and Specifications
13.5.3 Wuhan Institute of Biological Products Pertussis Vaccination Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Wuhan Institute of Biological Products Main Business Overview
13.5.5 Wuhan Institute of Biological Products Latest Developments
13.6 Walvax Biotechnology
13.6.1 Walvax Biotechnology Company Information
13.6.2 Walvax Biotechnology Pertussis Vaccination Product Portfolios and Specifications
13.6.3 Walvax Biotechnology Pertussis Vaccination Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Walvax Biotechnology Main Business Overview
13.6.5 Walvax Biotechnology Latest Developments
13.7 Chengdu Institute of Biological Products
13.7.1 Chengdu Institute of Biological Products Company Information
13.7.2 Chengdu Institute of Biological Products Pertussis Vaccination Product Portfolios and Specifications
13.7.3 Chengdu Institute of Biological Products Pertussis Vaccination Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Chengdu Institute of Biological Products Main Business Overview
13.7.5 Chengdu Institute of Biological Products Latest Developments
13.8 Minhai Biotechnology
13.8.1 Minhai Biotechnology Company Information
13.8.2 Minhai Biotechnology Pertussis Vaccination Product Portfolios and Specifications
13.8.3 Minhai Biotechnology Pertussis Vaccination Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Minhai Biotechnology Main Business Overview
13.8.5 Minhai Biotechnology Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Pertussis Vaccination Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Pertussis Vaccination Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Acellular Vaccines
Table 4. Major Players of Whole-cell Vaccines
Table 5. Global Pertussis Vaccination Sales by Type (2018-2023) & (Units)
Table 6. Global Pertussis Vaccination Sales Market Share by Type (2018-2023)
Table 7. Global Pertussis Vaccination Revenue by Type (2018-2023) & ($ million)
Table 8. Global Pertussis Vaccination Revenue Market Share by Type (2018-2023)
Table 9. Global Pertussis Vaccination Sale Price by Type (2018-2023) & (US$/Unit)
Table 10. Global Pertussis Vaccination Sales by Application (2018-2023) & (Units)
Table 11. Global Pertussis Vaccination Sales Market Share by Application (2018-2023)
Table 12. Global Pertussis Vaccination Revenue by Application (2018-2023)
Table 13. Global Pertussis Vaccination Revenue Market Share by Application (2018-2023)
Table 14. Global Pertussis Vaccination Sale Price by Application (2018-2023) & (US$/Unit)
Table 15. Global Pertussis Vaccination Sales by Company (2018-2023) & (Units)
Table 16. Global Pertussis Vaccination Sales Market Share by Company (2018-2023)
Table 17. Global Pertussis Vaccination Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Pertussis Vaccination Revenue Market Share by Company (2018-2023)
Table 19. Global Pertussis Vaccination Sale Price by Company (2018-2023) & (US$/Unit)
Table 20. Key Manufacturers Pertussis Vaccination Producing Area Distribution and Sales Area
Table 21. Players Pertussis Vaccination Products Offered
Table 22. Pertussis Vaccination Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Pertussis Vaccination Sales by Geographic Region (2018-2023) & (Units)
Table 26. Global Pertussis Vaccination Sales Market Share Geographic Region (2018-2023)
Table 27. Global Pertussis Vaccination Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Pertussis Vaccination Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Pertussis Vaccination Sales by Country/Region (2018-2023) & (Units)
Table 30. Global Pertussis Vaccination Sales Market Share by Country/Region (2018-2023)
Table 31. Global Pertussis Vaccination Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Pertussis Vaccination Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Pertussis Vaccination Sales by Country (2018-2023) & (Units)
Table 34. Americas Pertussis Vaccination Sales Market Share by Country (2018-2023)
Table 35. Americas Pertussis Vaccination Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Pertussis Vaccination Revenue Market Share by Country (2018-2023)
Table 37. Americas Pertussis Vaccination Sales by Type (2018-2023) & (Units)
Table 38. Americas Pertussis Vaccination Sales by Application (2018-2023) & (Units)
Table 39. APAC Pertussis Vaccination Sales by Region (2018-2023) & (Units)
Table 40. APAC Pertussis Vaccination Sales Market Share by Region (2018-2023)
Table 41. APAC Pertussis Vaccination Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Pertussis Vaccination Revenue Market Share by Region (2018-2023)
Table 43. APAC Pertussis Vaccination Sales by Type (2018-2023) & (Units)
Table 44. APAC Pertussis Vaccination Sales by Application (2018-2023) & (Units)
Table 45. Europe Pertussis Vaccination Sales by Country (2018-2023) & (Units)
Table 46. Europe Pertussis Vaccination Sales Market Share by Country (2018-2023)
Table 47. Europe Pertussis Vaccination Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Pertussis Vaccination Revenue Market Share by Country (2018-2023)
Table 49. Europe Pertussis Vaccination Sales by Type (2018-2023) & (Units)
Table 50. Europe Pertussis Vaccination Sales by Application (2018-2023) & (Units)
Table 51. Middle East & Africa Pertussis Vaccination Sales by Country (2018-2023) & (Units)
Table 52. Middle East & Africa Pertussis Vaccination Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Pertussis Vaccination Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Pertussis Vaccination Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Pertussis Vaccination Sales by Type (2018-2023) & (Units)
Table 56. Middle East & Africa Pertussis Vaccination Sales by Application (2018-2023) & (Units)
Table 57. Key Market Drivers & Growth Opportunities of Pertussis Vaccination
Table 58. Key Market Challenges & Risks of Pertussis Vaccination
Table 59. Key Industry Trends of Pertussis Vaccination
Table 60. Pertussis Vaccination Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Pertussis Vaccination Distributors List
Table 63. Pertussis Vaccination Customer List
Table 64. Global Pertussis Vaccination Sales Forecast by Region (2024-2029) & (Units)
Table 65. Global Pertussis Vaccination Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Pertussis Vaccination Sales Forecast by Country (2024-2029) & (Units)
Table 67. Americas Pertussis Vaccination Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Pertussis Vaccination Sales Forecast by Region (2024-2029) & (Units)
Table 69. APAC Pertussis Vaccination Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Pertussis Vaccination Sales Forecast by Country (2024-2029) & (Units)
Table 71. Europe Pertussis Vaccination Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Pertussis Vaccination Sales Forecast by Country (2024-2029) & (Units)
Table 73. Middle East & Africa Pertussis Vaccination Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Pertussis Vaccination Sales Forecast by Type (2024-2029) & (Units)
Table 75. Global Pertussis Vaccination Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Pertussis Vaccination Sales Forecast by Application (2024-2029) & (Units)
Table 77. Global Pertussis Vaccination Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. Sanofi Pasteur Basic Information, Pertussis Vaccination Manufacturing Base, Sales Area and Its Competitors
Table 79. Sanofi Pasteur Pertussis Vaccination Product Portfolios and Specifications
Table 80. Sanofi Pasteur Pertussis Vaccination Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 81. Sanofi Pasteur Main Business
Table 82. Sanofi Pasteur Latest Developments
Table 83. GSK Basic Information, Pertussis Vaccination Manufacturing Base, Sales Area and Its Competitors
Table 84. GSK Pertussis Vaccination Product Portfolios and Specifications
Table 85. GSK Pertussis Vaccination Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 86. GSK Main Business
Table 87. GSK Latest Developments
Table 88. Mitsubishi Tanabe Pharma Basic Information, Pertussis Vaccination Manufacturing Base, Sales Area and Its Competitors
Table 89. Mitsubishi Tanabe Pharma Pertussis Vaccination Product Portfolios and Specifications
Table 90. Mitsubishi Tanabe Pharma Pertussis Vaccination Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 91. Mitsubishi Tanabe Pharma Main Business
Table 92. Mitsubishi Tanabe Pharma Latest Developments
Table 93. KM Biologics Basic Information, Pertussis Vaccination Manufacturing Base, Sales Area and Its Competitors
Table 94. KM Biologics Pertussis Vaccination Product Portfolios and Specifications
Table 95. KM Biologics Pertussis Vaccination Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 96. KM Biologics Main Business
Table 97. KM Biologics Latest Developments
Table 98. Wuhan Institute of Biological Products Basic Information, Pertussis Vaccination Manufacturing Base, Sales Area and Its Competitors
Table 99. Wuhan Institute of Biological Products Pertussis Vaccination Product Portfolios and Specifications
Table 100. Wuhan Institute of Biological Products Pertussis Vaccination Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 101. Wuhan Institute of Biological Products Main Business
Table 102. Wuhan Institute of Biological Products Latest Developments
Table 103. Walvax Biotechnology Basic Information, Pertussis Vaccination Manufacturing Base, Sales Area and Its Competitors
Table 104. Walvax Biotechnology Pertussis Vaccination Product Portfolios and Specifications
Table 105. Walvax Biotechnology Pertussis Vaccination Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 106. Walvax Biotechnology Main Business
Table 107. Walvax Biotechnology Latest Developments
Table 108. Chengdu Institute of Biological Products Basic Information, Pertussis Vaccination Manufacturing Base, Sales Area and Its Competitors
Table 109. Chengdu Institute of Biological Products Pertussis Vaccination Product Portfolios and Specifications
Table 110. Chengdu Institute of Biological Products Pertussis Vaccination Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 111. Chengdu Institute of Biological Products Main Business
Table 112. Chengdu Institute of Biological Products Latest Developments
Table 113. Minhai Biotechnology Basic Information, Pertussis Vaccination Manufacturing Base, Sales Area and Its Competitors
Table 114. Minhai Biotechnology Pertussis Vaccination Product Portfolios and Specifications
Table 115. Minhai Biotechnology Pertussis Vaccination Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 116. Minhai Biotechnology Main Business
Table 117. Minhai Biotechnology Latest Developments
Table 1. Pertussis Vaccination Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Pertussis Vaccination Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Acellular Vaccines
Table 4. Major Players of Whole-cell Vaccines
Table 5. Global Pertussis Vaccination Sales by Type (2018-2023) & (Units)
Table 6. Global Pertussis Vaccination Sales Market Share by Type (2018-2023)
Table 7. Global Pertussis Vaccination Revenue by Type (2018-2023) & ($ million)
Table 8. Global Pertussis Vaccination Revenue Market Share by Type (2018-2023)
Table 9. Global Pertussis Vaccination Sale Price by Type (2018-2023) & (US$/Unit)
Table 10. Global Pertussis Vaccination Sales by Application (2018-2023) & (Units)
Table 11. Global Pertussis Vaccination Sales Market Share by Application (2018-2023)
Table 12. Global Pertussis Vaccination Revenue by Application (2018-2023)
Table 13. Global Pertussis Vaccination Revenue Market Share by Application (2018-2023)
Table 14. Global Pertussis Vaccination Sale Price by Application (2018-2023) & (US$/Unit)
Table 15. Global Pertussis Vaccination Sales by Company (2018-2023) & (Units)
Table 16. Global Pertussis Vaccination Sales Market Share by Company (2018-2023)
Table 17. Global Pertussis Vaccination Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Pertussis Vaccination Revenue Market Share by Company (2018-2023)
Table 19. Global Pertussis Vaccination Sale Price by Company (2018-2023) & (US$/Unit)
Table 20. Key Manufacturers Pertussis Vaccination Producing Area Distribution and Sales Area
Table 21. Players Pertussis Vaccination Products Offered
Table 22. Pertussis Vaccination Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Pertussis Vaccination Sales by Geographic Region (2018-2023) & (Units)
Table 26. Global Pertussis Vaccination Sales Market Share Geographic Region (2018-2023)
Table 27. Global Pertussis Vaccination Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Pertussis Vaccination Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Pertussis Vaccination Sales by Country/Region (2018-2023) & (Units)
Table 30. Global Pertussis Vaccination Sales Market Share by Country/Region (2018-2023)
Table 31. Global Pertussis Vaccination Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Pertussis Vaccination Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Pertussis Vaccination Sales by Country (2018-2023) & (Units)
Table 34. Americas Pertussis Vaccination Sales Market Share by Country (2018-2023)
Table 35. Americas Pertussis Vaccination Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Pertussis Vaccination Revenue Market Share by Country (2018-2023)
Table 37. Americas Pertussis Vaccination Sales by Type (2018-2023) & (Units)
Table 38. Americas Pertussis Vaccination Sales by Application (2018-2023) & (Units)
Table 39. APAC Pertussis Vaccination Sales by Region (2018-2023) & (Units)
Table 40. APAC Pertussis Vaccination Sales Market Share by Region (2018-2023)
Table 41. APAC Pertussis Vaccination Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Pertussis Vaccination Revenue Market Share by Region (2018-2023)
Table 43. APAC Pertussis Vaccination Sales by Type (2018-2023) & (Units)
Table 44. APAC Pertussis Vaccination Sales by Application (2018-2023) & (Units)
Table 45. Europe Pertussis Vaccination Sales by Country (2018-2023) & (Units)
Table 46. Europe Pertussis Vaccination Sales Market Share by Country (2018-2023)
Table 47. Europe Pertussis Vaccination Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Pertussis Vaccination Revenue Market Share by Country (2018-2023)
Table 49. Europe Pertussis Vaccination Sales by Type (2018-2023) & (Units)
Table 50. Europe Pertussis Vaccination Sales by Application (2018-2023) & (Units)
Table 51. Middle East & Africa Pertussis Vaccination Sales by Country (2018-2023) & (Units)
Table 52. Middle East & Africa Pertussis Vaccination Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Pertussis Vaccination Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Pertussis Vaccination Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Pertussis Vaccination Sales by Type (2018-2023) & (Units)
Table 56. Middle East & Africa Pertussis Vaccination Sales by Application (2018-2023) & (Units)
Table 57. Key Market Drivers & Growth Opportunities of Pertussis Vaccination
Table 58. Key Market Challenges & Risks of Pertussis Vaccination
Table 59. Key Industry Trends of Pertussis Vaccination
Table 60. Pertussis Vaccination Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Pertussis Vaccination Distributors List
Table 63. Pertussis Vaccination Customer List
Table 64. Global Pertussis Vaccination Sales Forecast by Region (2024-2029) & (Units)
Table 65. Global Pertussis Vaccination Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Pertussis Vaccination Sales Forecast by Country (2024-2029) & (Units)
Table 67. Americas Pertussis Vaccination Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Pertussis Vaccination Sales Forecast by Region (2024-2029) & (Units)
Table 69. APAC Pertussis Vaccination Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Pertussis Vaccination Sales Forecast by Country (2024-2029) & (Units)
Table 71. Europe Pertussis Vaccination Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Pertussis Vaccination Sales Forecast by Country (2024-2029) & (Units)
Table 73. Middle East & Africa Pertussis Vaccination Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Pertussis Vaccination Sales Forecast by Type (2024-2029) & (Units)
Table 75. Global Pertussis Vaccination Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Pertussis Vaccination Sales Forecast by Application (2024-2029) & (Units)
Table 77. Global Pertussis Vaccination Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. Sanofi Pasteur Basic Information, Pertussis Vaccination Manufacturing Base, Sales Area and Its Competitors
Table 79. Sanofi Pasteur Pertussis Vaccination Product Portfolios and Specifications
Table 80. Sanofi Pasteur Pertussis Vaccination Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 81. Sanofi Pasteur Main Business
Table 82. Sanofi Pasteur Latest Developments
Table 83. GSK Basic Information, Pertussis Vaccination Manufacturing Base, Sales Area and Its Competitors
Table 84. GSK Pertussis Vaccination Product Portfolios and Specifications
Table 85. GSK Pertussis Vaccination Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 86. GSK Main Business
Table 87. GSK Latest Developments
Table 88. Mitsubishi Tanabe Pharma Basic Information, Pertussis Vaccination Manufacturing Base, Sales Area and Its Competitors
Table 89. Mitsubishi Tanabe Pharma Pertussis Vaccination Product Portfolios and Specifications
Table 90. Mitsubishi Tanabe Pharma Pertussis Vaccination Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 91. Mitsubishi Tanabe Pharma Main Business
Table 92. Mitsubishi Tanabe Pharma Latest Developments
Table 93. KM Biologics Basic Information, Pertussis Vaccination Manufacturing Base, Sales Area and Its Competitors
Table 94. KM Biologics Pertussis Vaccination Product Portfolios and Specifications
Table 95. KM Biologics Pertussis Vaccination Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 96. KM Biologics Main Business
Table 97. KM Biologics Latest Developments
Table 98. Wuhan Institute of Biological Products Basic Information, Pertussis Vaccination Manufacturing Base, Sales Area and Its Competitors
Table 99. Wuhan Institute of Biological Products Pertussis Vaccination Product Portfolios and Specifications
Table 100. Wuhan Institute of Biological Products Pertussis Vaccination Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 101. Wuhan Institute of Biological Products Main Business
Table 102. Wuhan Institute of Biological Products Latest Developments
Table 103. Walvax Biotechnology Basic Information, Pertussis Vaccination Manufacturing Base, Sales Area and Its Competitors
Table 104. Walvax Biotechnology Pertussis Vaccination Product Portfolios and Specifications
Table 105. Walvax Biotechnology Pertussis Vaccination Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 106. Walvax Biotechnology Main Business
Table 107. Walvax Biotechnology Latest Developments
Table 108. Chengdu Institute of Biological Products Basic Information, Pertussis Vaccination Manufacturing Base, Sales Area and Its Competitors
Table 109. Chengdu Institute of Biological Products Pertussis Vaccination Product Portfolios and Specifications
Table 110. Chengdu Institute of Biological Products Pertussis Vaccination Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 111. Chengdu Institute of Biological Products Main Business
Table 112. Chengdu Institute of Biological Products Latest Developments
Table 113. Minhai Biotechnology Basic Information, Pertussis Vaccination Manufacturing Base, Sales Area and Its Competitors
Table 114. Minhai Biotechnology Pertussis Vaccination Product Portfolios and Specifications
Table 115. Minhai Biotechnology Pertussis Vaccination Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 116. Minhai Biotechnology Main Business
Table 117. Minhai Biotechnology Latest Developments
LIST OF FIGURES
Figure 1. Picture of Pertussis Vaccination
Figure 2. Pertussis Vaccination Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Pertussis Vaccination Sales Growth Rate 2018-2029 (Units)
Figure 7. Global Pertussis Vaccination Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Pertussis Vaccination Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Acellular Vaccines
Figure 10. Product Picture of Whole-cell Vaccines
Figure 11. Global Pertussis Vaccination Sales Market Share by Type in 2022
Figure 12. Global Pertussis Vaccination Revenue Market Share by Type (2018-2023)
Figure 13. Pertussis Vaccination Consumed in 12 Months Below
Figure 14. Global Pertussis Vaccination Market: 12 Months Below (2018-2023) & (Units)
Figure 15. Pertussis Vaccination Consumed in 12 Months Above
Figure 16. Global Pertussis Vaccination Market: 12 Months Above (2018-2023) & (Units)
Figure 17. Global Pertussis Vaccination Sales Market Share by Application (2022)
Figure 18. Global Pertussis Vaccination Revenue Market Share by Application in 2022
Figure 19. Pertussis Vaccination Sales Market by Company in 2022 (Units)
Figure 20. Global Pertussis Vaccination Sales Market Share by Company in 2022
Figure 21. Pertussis Vaccination Revenue Market by Company in 2022 ($ Million)
Figure 22. Global Pertussis Vaccination Revenue Market Share by Company in 2022
Figure 23. Global Pertussis Vaccination Sales Market Share by Geographic Region (2018-2023)
Figure 24. Global Pertussis Vaccination Revenue Market Share by Geographic Region in 2022
Figure 25. Americas Pertussis Vaccination Sales 2018-2023 (Units)
Figure 26. Americas Pertussis Vaccination Revenue 2018-2023 ($ Millions)
Figure 27. APAC Pertussis Vaccination Sales 2018-2023 (Units)
Figure 28. APAC Pertussis Vaccination Revenue 2018-2023 ($ Millions)
Figure 29. Europe Pertussis Vaccination Sales 2018-2023 (Units)
Figure 30. Europe Pertussis Vaccination Revenue 2018-2023 ($ Millions)
Figure 31. Middle East & Africa Pertussis Vaccination Sales 2018-2023 (Units)
Figure 32. Middle East & Africa Pertussis Vaccination Revenue 2018-2023 ($ Millions)
Figure 33. Americas Pertussis Vaccination Sales Market Share by Country in 2022
Figure 34. Americas Pertussis Vaccination Revenue Market Share by Country in 2022
Figure 35. Americas Pertussis Vaccination Sales Market Share by Type (2018-2023)
Figure 36. Americas Pertussis Vaccination Sales Market Share by Application (2018-2023)
Figure 37. United States Pertussis Vaccination Revenue Growth 2018-2023 ($ Millions)
Figure 38. Canada Pertussis Vaccination Revenue Growth 2018-2023 ($ Millions)
Figure 39. Mexico Pertussis Vaccination Revenue Growth 2018-2023 ($ Millions)
Figure 40. Brazil Pertussis Vaccination Revenue Growth 2018-2023 ($ Millions)
Figure 41. APAC Pertussis Vaccination Sales Market Share by Region in 2022
Figure 42. APAC Pertussis Vaccination Revenue Market Share by Regions in 2022
Figure 43. APAC Pertussis Vaccination Sales Market Share by Type (2018-2023)
Figure 44. APAC Pertussis Vaccination Sales Market Share by Application (2018-2023)
Figure 45. China Pertussis Vaccination Revenue Growth 2018-2023 ($ Millions)
Figure 46. Japan Pertussis Vaccination Revenue Growth 2018-2023 ($ Millions)
Figure 47. South Korea Pertussis Vaccination Revenue Growth 2018-2023 ($ Millions)
Figure 48. Southeast Asia Pertussis Vaccination Revenue Growth 2018-2023 ($ Millions)
Figure 49. India Pertussis Vaccination Revenue Growth 2018-2023 ($ Millions)
Figure 50. Australia Pertussis Vaccination Revenue Growth 2018-2023 ($ Millions)
Figure 51. China Taiwan Pertussis Vaccination Revenue Growth 2018-2023 ($ Millions)
Figure 52. Europe Pertussis Vaccination Sales Market Share by Country in 2022
Figure 53. Europe Pertussis Vaccination Revenue Market Share by Country in 2022
Figure 54. Europe Pertussis Vaccination Sales Market Share by Type (2018-2023)
Figure 55. Europe Pertussis Vaccination Sales Market Share by Application (2018-2023)
Figure 56. Germany Pertussis Vaccination Revenue Growth 2018-2023 ($ Millions)
Figure 57. France Pertussis Vaccination Revenue Growth 2018-2023 ($ Millions)
Figure 58. UK Pertussis Vaccination Revenue Growth 2018-2023 ($ Millions)
Figure 59. Italy Pertussis Vaccination Revenue Growth 2018-2023 ($ Millions)
Figure 60. Russia Pertussis Vaccination Revenue Growth 2018-2023 ($ Millions)
Figure 61. Middle East & Africa Pertussis Vaccination Sales Market Share by Country in 2022
Figure 62. Middle East & Africa Pertussis Vaccination Revenue Market Share by Country in 2022
Figure 63. Middle East & Africa Pertussis Vaccination Sales Market Share by Type (2018-2023)
Figure 64. Middle East & Africa Pertussis Vaccination Sales Market Share by Application (2018-2023)
Figure 65. Egypt Pertussis Vaccination Revenue Growth 2018-2023 ($ Millions)
Figure 66. South Africa Pertussis Vaccination Revenue Growth 2018-2023 ($ Millions)
Figure 67. Israel Pertussis Vaccination Revenue Growth 2018-2023 ($ Millions)
Figure 68. Turkey Pertussis Vaccination Revenue Growth 2018-2023 ($ Millions)
Figure 69. GCC Country Pertussis Vaccination Revenue Growth 2018-2023 ($ Millions)
Figure 70. Manufacturing Cost Structure Analysis of Pertussis Vaccination in 2022
Figure 71. Manufacturing Process Analysis of Pertussis Vaccination
Figure 72. Industry Chain Structure of Pertussis Vaccination
Figure 73. Channels of Distribution
Figure 74. Global Pertussis Vaccination Sales Market Forecast by Region (2024-2029)
Figure 75. Global Pertussis Vaccination Revenue Market Share Forecast by Region (2024-2029)
Figure 76. Global Pertussis Vaccination Sales Market Share Forecast by Type (2024-2029)
Figure 77. Global Pertussis Vaccination Revenue Market Share Forecast by Type (2024-2029)
Figure 78. Global Pertussis Vaccination Sales Market Share Forecast by Application (2024-2029)
Figure 79. Global Pertussis Vaccination Revenue Market Share Forecast by Application (2024-2029)
Figure 1. Picture of Pertussis Vaccination
Figure 2. Pertussis Vaccination Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Pertussis Vaccination Sales Growth Rate 2018-2029 (Units)
Figure 7. Global Pertussis Vaccination Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Pertussis Vaccination Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Acellular Vaccines
Figure 10. Product Picture of Whole-cell Vaccines
Figure 11. Global Pertussis Vaccination Sales Market Share by Type in 2022
Figure 12. Global Pertussis Vaccination Revenue Market Share by Type (2018-2023)
Figure 13. Pertussis Vaccination Consumed in 12 Months Below
Figure 14. Global Pertussis Vaccination Market: 12 Months Below (2018-2023) & (Units)
Figure 15. Pertussis Vaccination Consumed in 12 Months Above
Figure 16. Global Pertussis Vaccination Market: 12 Months Above (2018-2023) & (Units)
Figure 17. Global Pertussis Vaccination Sales Market Share by Application (2022)
Figure 18. Global Pertussis Vaccination Revenue Market Share by Application in 2022
Figure 19. Pertussis Vaccination Sales Market by Company in 2022 (Units)
Figure 20. Global Pertussis Vaccination Sales Market Share by Company in 2022
Figure 21. Pertussis Vaccination Revenue Market by Company in 2022 ($ Million)
Figure 22. Global Pertussis Vaccination Revenue Market Share by Company in 2022
Figure 23. Global Pertussis Vaccination Sales Market Share by Geographic Region (2018-2023)
Figure 24. Global Pertussis Vaccination Revenue Market Share by Geographic Region in 2022
Figure 25. Americas Pertussis Vaccination Sales 2018-2023 (Units)
Figure 26. Americas Pertussis Vaccination Revenue 2018-2023 ($ Millions)
Figure 27. APAC Pertussis Vaccination Sales 2018-2023 (Units)
Figure 28. APAC Pertussis Vaccination Revenue 2018-2023 ($ Millions)
Figure 29. Europe Pertussis Vaccination Sales 2018-2023 (Units)
Figure 30. Europe Pertussis Vaccination Revenue 2018-2023 ($ Millions)
Figure 31. Middle East & Africa Pertussis Vaccination Sales 2018-2023 (Units)
Figure 32. Middle East & Africa Pertussis Vaccination Revenue 2018-2023 ($ Millions)
Figure 33. Americas Pertussis Vaccination Sales Market Share by Country in 2022
Figure 34. Americas Pertussis Vaccination Revenue Market Share by Country in 2022
Figure 35. Americas Pertussis Vaccination Sales Market Share by Type (2018-2023)
Figure 36. Americas Pertussis Vaccination Sales Market Share by Application (2018-2023)
Figure 37. United States Pertussis Vaccination Revenue Growth 2018-2023 ($ Millions)
Figure 38. Canada Pertussis Vaccination Revenue Growth 2018-2023 ($ Millions)
Figure 39. Mexico Pertussis Vaccination Revenue Growth 2018-2023 ($ Millions)
Figure 40. Brazil Pertussis Vaccination Revenue Growth 2018-2023 ($ Millions)
Figure 41. APAC Pertussis Vaccination Sales Market Share by Region in 2022
Figure 42. APAC Pertussis Vaccination Revenue Market Share by Regions in 2022
Figure 43. APAC Pertussis Vaccination Sales Market Share by Type (2018-2023)
Figure 44. APAC Pertussis Vaccination Sales Market Share by Application (2018-2023)
Figure 45. China Pertussis Vaccination Revenue Growth 2018-2023 ($ Millions)
Figure 46. Japan Pertussis Vaccination Revenue Growth 2018-2023 ($ Millions)
Figure 47. South Korea Pertussis Vaccination Revenue Growth 2018-2023 ($ Millions)
Figure 48. Southeast Asia Pertussis Vaccination Revenue Growth 2018-2023 ($ Millions)
Figure 49. India Pertussis Vaccination Revenue Growth 2018-2023 ($ Millions)
Figure 50. Australia Pertussis Vaccination Revenue Growth 2018-2023 ($ Millions)
Figure 51. China Taiwan Pertussis Vaccination Revenue Growth 2018-2023 ($ Millions)
Figure 52. Europe Pertussis Vaccination Sales Market Share by Country in 2022
Figure 53. Europe Pertussis Vaccination Revenue Market Share by Country in 2022
Figure 54. Europe Pertussis Vaccination Sales Market Share by Type (2018-2023)
Figure 55. Europe Pertussis Vaccination Sales Market Share by Application (2018-2023)
Figure 56. Germany Pertussis Vaccination Revenue Growth 2018-2023 ($ Millions)
Figure 57. France Pertussis Vaccination Revenue Growth 2018-2023 ($ Millions)
Figure 58. UK Pertussis Vaccination Revenue Growth 2018-2023 ($ Millions)
Figure 59. Italy Pertussis Vaccination Revenue Growth 2018-2023 ($ Millions)
Figure 60. Russia Pertussis Vaccination Revenue Growth 2018-2023 ($ Millions)
Figure 61. Middle East & Africa Pertussis Vaccination Sales Market Share by Country in 2022
Figure 62. Middle East & Africa Pertussis Vaccination Revenue Market Share by Country in 2022
Figure 63. Middle East & Africa Pertussis Vaccination Sales Market Share by Type (2018-2023)
Figure 64. Middle East & Africa Pertussis Vaccination Sales Market Share by Application (2018-2023)
Figure 65. Egypt Pertussis Vaccination Revenue Growth 2018-2023 ($ Millions)
Figure 66. South Africa Pertussis Vaccination Revenue Growth 2018-2023 ($ Millions)
Figure 67. Israel Pertussis Vaccination Revenue Growth 2018-2023 ($ Millions)
Figure 68. Turkey Pertussis Vaccination Revenue Growth 2018-2023 ($ Millions)
Figure 69. GCC Country Pertussis Vaccination Revenue Growth 2018-2023 ($ Millions)
Figure 70. Manufacturing Cost Structure Analysis of Pertussis Vaccination in 2022
Figure 71. Manufacturing Process Analysis of Pertussis Vaccination
Figure 72. Industry Chain Structure of Pertussis Vaccination
Figure 73. Channels of Distribution
Figure 74. Global Pertussis Vaccination Sales Market Forecast by Region (2024-2029)
Figure 75. Global Pertussis Vaccination Revenue Market Share Forecast by Region (2024-2029)
Figure 76. Global Pertussis Vaccination Sales Market Share Forecast by Type (2024-2029)
Figure 77. Global Pertussis Vaccination Revenue Market Share Forecast by Type (2024-2029)
Figure 78. Global Pertussis Vaccination Sales Market Share Forecast by Application (2024-2029)
Figure 79. Global Pertussis Vaccination Revenue Market Share Forecast by Application (2024-2029)